End-to-End Deployment of Single-Use Technology in Aseptic Filling of Vaccines at GSK - How this Big Pharma company successfully implemented disposable technologies in its manufacturing plant. - BioPha

ADVERTISEMENT

End-to-End Deployment of Single-Use Technology in Aseptic Filling of Vaccines at GSK
How this Big Pharma company successfully implemented disposable technologies in its manufacturing plant.


BioPharm International
Volume 23, Issue 2

MM: How was the project managed? What type of team did you put in place?


Figure 1. Getinge La Calhene DPTE aseptic transfer system with disposable beta port for transfer of pre-assembled manifold bags assembled with Bosch needles
NB: The new product introduction department set up the URS, working in collaboration with the quality and engineering departments. Nigel Wood, our engineering project manager, played an important part, particularly looking at the integration of the Bosch system, as did our quality assurance (QA) department which took a pragmatic approach to making sound, risk-based decisions. We also worked in close collaboration with the Millipore Mobius experts.

We carried out a full critical review of all aspects of the filling systems and identified many areas of over complication. We challenged each of these aspects with local QA, then Millipore Mobius expert advisors, and then with the MHRA regulators. We took the approach that every item, regardless of its excellence or complexity, has a failure rate. Thus any reduction in items will have a beneficial effect, and many component parts were removed or at least reduced in complexity.

Other principles were that the product passage from point 1 to 2 should be as simple as possible with as few manipulations as possible (to reduce training and error rates) and wherever practical, as few grade A manipulations as possible. No aseptic connections (including needle assembly) means no SIP to point-of-fill, and minimal grade A intrusions. Our other main motto is, "where there are connections, use the best available."

EJ: Our approach on such a project is to work hand-in-hand with the end-user, a collaborative approach aimed at finding the best overall solution.

DISPOSABLES SELECTION AND IMPLEMENTATION

MM: How did you evaluate the operational aspects of the technology and the cost of the options? How did you go about risk mitigation?

NB: If it hadn't been for the pandemic, the selection and implementation of disposables would no doubt have taken twice as long. In this situation, convincing the sponsors was somewhat quicker than in a normal situation. QA pragmatism through risk assessment also helped immensely.


Figure 2. Bosch single-use filling needles. GSK's use of Bosch needles began early in the development of the Bosch systems. The Bosch manufacturing process has been improved to control all aspects of quality control, including chemical and microbial levels.
One of the key technologies we selected was the Millipore Mobius magnetic drive mixer for bulk drug formulation. We had already done previous testing with this system and found it to work efficiently. The Millipore STS connector was used to secure the sterile connection of the irradiated filter in the grade C environment. In both cases, we went through a series of trials and training, using 10 assemblies for each connection for each process step. It is important that the operators are trained to make the connection, because if you don't make the final click properly it can leak. We chose 50-L bags from Sartorius Stedim Biotech for the bulk drug hold. We selected the Sartorius Stedim bags because we preferred the integrity testing methodology that they have developed. We also carried out a full risk assessment using failure mode effect analysis (FMEA).Other key technologies included the Getinge La Calhene aseptic transfer system, which was premounted with the disposable beta transfer port to allow aseptic transfer of the seven pre-assembled manifold bags mounted with the Bosch needles into the RABs.

The Millipore team worked to rapidly qualify the assembly of the Bosch needles on the manifold—not a simple task when ensuring the safety of the disposable assembly prepacked with stainless steel needles. The peristaltic pump filling systems from Groninger and Bosch were selected for their high level of accuracy and simplicity. We also work with ready-to-use presterilized stoppers from Helvoet & West Pharma, again eliminating washing requirements.

EJ: Cost was not the primary concern for pandemic flu. Time to get a solution and flow path security and sterility were the primary drivers. For other applications, GSK had a cost target, but was flexible with this as they learned of the operational efficiencies they would gain in using a single-use solution.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here